A new study, presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery® (SVS) reviewed data on the influence of contralateral carotid occlusion (CCO) on carotid endarterectomy (CEA) and carotid artery stenting (CAS) for which there is a paucity of conflicting data.
Heart surgery patients can considerably reduce their risk of developing post-operative acute renal failure by taking aspirin for five days before undergoing surgery.
For patients with symptomatic carotid stenosis, endarterectomy has the greatest benefit compared with stenting among patients treated within 7 days of the most recent event, researchers found. The rate of any stroke or death within 30 days of the procedure was significantly higher for stenting than for surgery, regardless of the time since the latest event (7.7% versus 3.8%), according to Gustav Fraedrich, MD, of Innsbruck Medical University in Austria.
Branches following complex aortic aneurysm repair appear to be durable and are rarely the cause of patient death following complex aortic aneurysm repair according to a study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery®.
At two years, mechanochemical ablation (MOCA) is as efficacious as current endothermal techniques without the need of tumescent anaesthesia and is more effective than reported results of foam sclerotherapy of the great saphenous vein. Steve Elias, who presented the first-in-man two-year results with the technique at the Vascular Annual Meeting (Washington DC, USA,7–9 June 2012), said that MOCA is another alternative modality for most incompetent great and small saphenous veins.
Vascular News has heard from Cook Medical that on Wednesday 6 June, it received the CE mark for the world’s first off-the-shelf thoracoabdominal stent graft, the Zenith t-Branch Thoracoabdominal Endovascular Graft.
Medtronic, Inc. has announced the U.S. launch of the Endurant® II AAA Stent Graft System, which recently received approval from the U.S. Food and Drug Administration (FDA) for the minimally invasive treatment of abdominal aortic aneurysms through endovascular repair (EVAR), an alternative to major surgery. The Endurant II AAA System will be showcased at the Society for Vascular Surgery’s Vascular Annual Meeting, June 7–9 at National Harbor, Md., near Washington, D.C. Clinical performance updates on Medtronic s entire portfolio of aortic stent grafts will also be presented at the meeting.
Branches following complex aortic aneurysm repair appear to be durable and are rarely the cause of patient death following complex aortic aneurysm repair according to a study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery.
Vascular surgeons and researchers from the Mayo Clinic in Rochester, USA, and University of Tennessee at Chattanooga joined hands to compare outcomes of mesenteric angioplasty using percutaneous transluminal angioplasty and stenting with iCAST covered stents (Atrium) or bare metal stents in patients with chronic mesenteric ischaemia. Their findings were released at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery on 7 June 2012.
On 4 June 2012, Hansen Medical announced that it has received 510(k) clearance from the FDA for its Magellan Robotic System, including the catheter and accessories. The company will commence commercialisation at selected centres in the US immediately, with a full launch expected later in the year. The product will be presented at the 66th Vascular Annual Meeting of the Society for Vascular Surgery at National Harbor, from 7–9 June.
TriVascular announced on 4 June 2012 a US$60 million series D Preferred Stock equity financing commitment; the initial tranche of which closed on 1 June. New investor Kaiser Permanente Ventures, in partnership with the Redmile Group, led the round joining existing investors New Enterprise Associates, Delphi Ventures, MPM Capital, Kearny Venture Partners and Pinnacle Ventures. Sam Brasch, director at Kaiser Permanente Ventures, will join TriVascular’s Board of Directors.
W. L. Gore & Associates (Gore) today announced that the GORE® Hybrid Vascular Graft was awarded Gold Winner in the Implant and Tissue-Replacement Products category of the 2012 Medical Design Excellence Awards (MDEA) competition. The Gore Device is an expanded polytetrafluoroethylene (ePTFE) vascular prosthesis that provides a streamlined solution for challenging dialysis access, aortic debranching, and arterial bypass procedures. The award-winning prosthesis provides a new way in for better outflow and the potential to significantly improve patient outcomes.
Four-dimensional (4D) imaging techniques are available and can capture dynamic changes in blood flow and aortic morphology, and this type of technology can potentially be used for risk stratification and to guide treatment in individual patients undergoing endovascular thoracic aortic repair, Rachel Clough told delegates at the CX Symposium (14–17 April, London, UK).
MAQUET Cardiopulmonary, a business unit of MAQUET Cardiovascular and a leader in extracorporeal life support (ECLS) systems, today announced that they have signed an agreement with Avalon Laboratories to acquire its Avalon Elite® Bi-Caval Dual Lumen Catheter and complimentary vascular access kits for use during ECLS.
The Society for Vascular Surgery (SVS) and Gore have announced an initiative that recognises the contributions of female vascular surgeons and aims to advance the number of women entering the profession.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos